I

Ipsen Global

Global biopharma focused on specialty care

CDO Country Cluster Head

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA

About the Job

Requirements

  • A minimum of 10 years of experience in clinical trials.
  • Demonstrated experience leading Country Operations teams of different sizes and operational models across all trial types, including Site Management and Monitoring experience.
  • Demonstrated people or project management experience, such as leading project teams, operational teams, or cross-functional teams through operational change and transformation.
  • Extensive experience in clinical development, clinical operations, quality, compliance, or related areas in the pharmaceutical or biotech industry.
  • Demonstrated understanding of the clinical trial landscape and commitment to innovation, creativity, and operational excellence.
  • Extensive knowledge of drug development processes, ICH-GCP guidelines, 21 CFR Part 11, and major Health Authority regulations.
  • Experience in audit and inspection readiness, preparation, and conduct, with a track record of managing FDA/EMA inspections.
  • Experience in large-scale organizational change management or implementation programs.
  • Proven influencer and change agent with project management capabilities in planning, prioritization, problem solving, and organization; ability to manage multiple priorities in a dynamic environment and an agile mindset.
  • Experience managing internal stakeholders and communicating across all organizational levels, including executive leadership.
  • Strong understanding of clinical systems, including eTMF, CTMS, and QMS, and business process design.
  • Effective leadership skills and proven ability to foster team productivity and cohesiveness in a changing environment.
  • Financial acumen.
  • A minimum of a Bachelor's degree in a scientific discipline or general management is required.
  • English language proficiency is essential.

Responsibilities

  • Oversee Ipsen's Country Operations activities under a Functional Service Provider (FSP) delivery model, ensuring operational excellence throughout the clinical trial lifecycle at country and site level.
  • Ensure consistent, compliant, and high-quality execution of country-level studies in the Clinical Development Operations portfolio and provide governance and oversight of FSP partners delivering country- and site-level activities.
  • Ensure high-performing sites, reliable data, and effective investigator relationships across the global portfolio; act as the single point of accountability for country or cluster performance.
  • Manage Ipsen staff within the cluster, including Functional Managers, Cluster Trial Managers, and Principal Clinical Research Associates, and collaborate with FSP leadership and staff.
  • Partner with functional leaders and FSP partners to deliver clinical trials on time, within budget, and in line with quality standards.
  • Be accountable for country-level project delivery to agreed timelines, including patient recruitment targets.
  • Build, develop, and motivate a high-performing internal team and ensure FSP providers provide appropriate resources for delivery.
  • Drive continuous improvement of Clinical Operations processes and procedures to optimize development speed, quality, and regulatory compliance.
  • Provide end-to-end oversight of FSP partners delivering country feasibility and site identification, site selection and initiation, study start-up, recruitment, study and site management and monitoring, study close-out, and inspection readiness.
  • Contribute with Business Enablement and Compliance to creating a Study, Site Management, and Monitoring Process Framework.
  • Ensure consistent application of Ipsen standards, standard operating procedures, and quality expectations across FSP-delivered activities.
  • Build strong partnerships with FSP providers while maintaining independence and sponsor oversight at cluster or country level.
  • Lead escalation and remediation of performance, quality, or compliance issues related to country- or site-level execution.
  • Act as the senior Ipsen counterpart to FSP leadership within the cluster.
  • Influence and direct resourcing and staff capability decisions at country or cluster level.
  • Establish data-driven approaches to country feasibility and site selection with global functions to support optimal country and site choices.
  • Oversee site feasibility and validation to support realistic enrollment projections and operational planning.
  • Ensure compliant study start-up, including site contracting and budget negotiations, regulatory and ethics submissions with relevant stakeholders, and site initiation readiness.
  • Monitor start-up performance metrics and proactively address delays or bottlenecks.
  • Implement risk-based monitoring strategies in line with regulatory expectations and Ipsen standards.
  • Ensure monitoring delivery across on-site, remote, and centralized activities; investigational product compliance; source data verification; source document review; and data quality oversight.
  • Partner with Data Management, Biostatistics, and Central Monitoring to integrate oversight and risk mitigation; drive consistency in site execution, issue management, and protocol adherence.
  • Ensure timely and compliant study and site close-out across the portfolio and maintain continuous site- and country-level inspection readiness.
  • Oversee Trial Master File completeness and quality with TMF leadership, site documentation and essential-document quality, and inspection preparation with FSP partners and internal stakeholders.
  • Support country-focused regulatory inspections and audits as a senior sponsor representative for Study, Site Management, and Monitoring matters.
  • Own and implement the country- or cluster-level Site Engagement Strategy in alignment with clinical development priorities, therapeutic focus, and portfolio growth.
  • Use a structured understanding of the site landscape to identify priority and strategic sites, including high-performing operational sites, emerging or development sites important to pipeline growth, and sites in new or emerging therapeutic areas.
  • Be accountable for investigator-site health, including performance, recruitment, retention, and quality.
  • Partner with stakeholders such as Local Medical Affairs to implement a differentiated site engagement strategy and coordinate with global patient affairs to facilitate regional patient input into clinical trials where appropriate.
  • Own study-level site segmentation strategy at country or cluster level and, where necessary, coordinate a global asset site-segmentation plan.
  • Partner with external groups such as Patient Advocacy Groups to improve subject access and site performance where appropriate.
  • Understand cluster capabilities and communicate them to support global strategy, including access to country-specific registries and diagnostic-testing pathways and planned policy changes.
  • Define, build, and grow the internal Study, Site Management, and Monitoring organization, overseeing Cluster Trial Managers and Principal Clinical Research Associates.
  • Partner with groups such as Training to ensure the team is skilled and focused on delivery.
  • Ensure country-level Study, Site Management, and Monitoring activities comply with ICH-GCP, applicable regional and local regulations, and Ipsen standards, policies, and procedures.
  • Embed proactive risk identification and mitigation at site and country level; work with Quality Assurance on audit findings, corrective and preventive actions, and continuous improvement.
  • Promote quality, accountability, and patient safety across internal teams and FSP partners.
  • Oversee performance management for country-level Study, Site Management, and Monitoring activities.
  • Use operational, quality, and performance data to identify trends and risks, support evidence-based decisions, and improve efficiency and quality.
  • Deliver and improve country-level metrics, including start-up timelines, recruitment rates, data quality, and inspection outcomes.
  • Partner with Strategy and Operations and Business Enablement to improve reporting and oversight capabilities, including dashboards and key performance indicators.
  • Champion innovation, digital enablement, and simplification across site-level processes where appropriate.
  • Drive performance through data-driven insights, benchmarking, and targeted interventions at site and study level.
  • Lead and develop high-performing internal country and cluster teams and matrixed functions supporting Study, Site Management, and Monitoring.
  • Support resource forecasting and management.
  • Act as a key interface with stakeholders across Clinical Development, Quality, Regulatory, Medical, and Global Operations.
  • Embed continuous improvement and lead change, ensuring change-management practices are applied across the team.
  • Act as a senior external ambassador for Ipsen, engaging health authorities, investigators, site networks, pharmaceutical associations, and institutional leaders to strengthen Ipsen's reputation and access to high-value sites.

Desired Qualifications

  • Experience in Early Development in Oncology or in patients is preferred.
  • An advanced degree, such as a Master's, MBA, MD, PhD, or PharmD, is preferred.
  • Country or cluster language proficiency is preferred.

About the Company

Ipsen Global

Global biopharma focused on specialty care

Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boulogne-Billancourt, France
Founded
2005

Recently Posted Jobs

Explore more opportunities at Ipsen Global

See more jobs